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Heart rhythm is initialized and controlled by the Sinoatrial Node (SAN), the primary
pacemaker of the heart. The SAN is a heterogeneous multi-compartment structure
characterized by clusters of specialized cardiomyocytes enmeshed within strands of
connective tissue or fibrosis. Intranodal fibrosis is emerging as an important modulator
of structural and functional integrity of the SAN pacemaker complex. In adult human
hearts, fatty tissue and fibrosis insulate the SAN from the hyperpolarizing effect of the
surrounding atria while electrical communication between the SAN and right atrium
is restricted to discrete SAN conduction pathways. The amount of fibrosis within the
SAN is inversely correlated with heart rate, while age and heart size are positively
correlated with fibrosis. Pathological upregulation of fibrosis within the SAN may lead to
tachycardia-bradycardia arrhythmias and cardiac arrest, possibly due to SAN reentry and
exit block, and is associated with atrial fibrillation, ventricular arrhythmias, heart failure and
myocardial infarction. In this review, we will discuss current literature on the role of fibrosis
in normal SAN structure and function, as well as the causes and consequences of SAN
fibrosis upregulation in disease conditions.
Keywords: sinoatrial node, fibrosis, sinus node dysfunction, aging, exit block, sinoatrial reentry, atrial fibrillation,
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INTRODUCTION
“We might mention also that, in some of the pathological hearts cut
by us, sections of this region (i.e., the sinoatrial node) appeared to
show a definite increase in the amount of fibrous tissue present-a fact
of considerable importance...”
(Keith and Flack, 1907)
In the human heart, cardiac rhythm is initiated and regulated by
the primary pacemaker of the heart, the Sinoatrial Node (SAN)
(Keith and Flack, 1907; Lewis et al., 1910; James, 1961; Boineau
et al., 1988; Opthof, 1988; Boyett et al., 2000; Chandler et al.,
2009; Fedorov et al., 2010b). Initiation of heart rhythm occurs
within specialized cardiomyocytes of the SAN and is propagated
throughout the atria and ventricles by the cardiac conduction sys-
tem. Sinus NodeDysfunction (SND), also referred to as Sick Sinus
Syndrome (SSS), commonly translates into rhythm abnormali-
ties manifested as brady-arrhythmias or tachycardia-bradycardia
(tachy-brady) syndrome (Mangrum and DiMarco, 2000), which
are frequently associated with cardiac diseases including atrial fib-
rillation (AF), malignant ventricular arrhythmias, heart failure
(HF) and cardiac arrest (Luu et al., 1989; Sumitomo et al., 2007;
Faggioni et al., 2013; Hjortshoj et al., 2013; Alonso et al., 2014;
Jensen et al., 2014). With the aging population, it is projected that
the annual incidence of SND cases in the US will increase from
78,000 in 2012 to 172,000 in 2060 (Jensen et al., 2014). SND is the
predominant prognosis for electronic pacemaker implantation
(Mangrum and DiMarco, 2000; Packer et al., 2009; Greenspon
et al., 2012), emphasizing the important role that the SAN plays
in maintaining normal cardiac rhythm and in human arrhythmic
diseases.
Since the discovery of the SAN by Keith and Flack in 1907,
significant strides in our understanding of SAN pacemaker func-
tion (Lakatta and DiFrancesco, 2009) have allowed for new and
exciting therapeutic strategies to treat SAN disease, such as the
development of Ivabradine as a selective drug against inappropri-
ate SAN tachycardia (Cappato et al., 2012) and artificial biological
pacemakers (Miake et al., 2002; Rosen et al., 2004; Rosen, 2014).
The heterogeneous distribution of specialized ion channels, intra-
cellular sodium/calcium handling proteins, gap junction channels
and receptors within the SAN pacemaker complex are a few of
the critical players shown to be involved in SAN pacemaking that
have been addressed in recent reviews (Monfredi et al., 2010;
Dobrzynski et al., 2013; Wu and Anderson, 2014). In addition
to these molecular mechanisms, the passive, structural features
of the SAN complex also contributes significantly to its normal
functioning.
In contrast to the simplified SAN structure in many text-
books, studies in both human and canine hearts have revealed
that the SAN is a complex multi-compartment structure (James,
1961; Opthof, 1988; Boineau et al., 1989; Beau et al., 1995; Boyett
et al., 2000; Sanchez-Quintana et al., 2005; Chandler et al., 2009;
Fedorov et al., 2009, 2010a). The SAN, in almost all mammalian
hearts, is characterized by clusters of specialized cardiomyocytes,
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enmeshed within strands of connective tissue or fibrosis, mostly
a combination of collagen, elastin and fibroblasts (Lev, 1954;
Hudson, 1960; Truex et al., 1967; Sanchez-Quintana et al., 2002).
This fibrotic matrix provides mechanical protection (Alings et al.,
1995) of the SAN and electrically insulates the SAN pacemaker
cells from the surrounding atrial myocardium, thereby efficiently
regulating normal sinus rhythm. This review will take a more in
depth look at the role of fibrosis in normal SAN function, as well
as factors involved in unfavorable fibrosis production observed in
patients and animal models with cardiac diseases and SND (Liu
et al., 2007; de Jong et al., 2011; Nakao et al., 2012; Glukhov et al.,
2013, 2015; Alonso et al., 2014; Jensen et al., 2014; Morris and
Kalman, 2014).
FIBROSIS IN NORMAL SAN FUNCTION
FIBROSIS DEFINES SAN STRUCTURE AND MAINTAINS FUNCTIONAL
INTEGRITY OF THE PACEMAKER COMPLEX
The SAN is anatomically located at the junction of the superior
vena cava and right atrium in the mammalian heart (Figure 1A).
In the normal adult human heart, the SAN is 12–20mm long
and 2–6mm wide, identified by its ellipsoidal shape that tra-
verses intramurally. The superior part (head) lies about 1mm
beneath the epicardium, separated by a layer of connective tis-
sue and fat (Keith and Flack, 1907; James, 1961; Truex et al., 1967;
Matsuyama et al., 2004; Sanchez-Quintana et al., 2005). The SAN
spreads from its head inferiorly for 10–20mm remaining beneath
the sulcus terminalis and just above the crista terminalis and has
several extensions into the surrounding atrial myocardium, form-
ing the specialized sinoatrial conduction pathways (SACPs) (Lev,
1954; Hudson, 1960; Demoulin and Kulbertus, 1978; Fedorov
et al., 2010b) (Figure 1A). Importantly, the SAN consists of small
clusters of pacemakermyocytes, arranged in parallel rows that fre-
quently anastomose. Dense connective tissue, nerve fibers, and
capillaries are interspersed with the SAN pacemaker clusters,
creating the SAN pacemaker complex.
A century ago, Keith and Flack’s pioneering studies described
fibrotic insulation in the human SAN: “In the human heart the
fibers (i.e., SAN pacemaker cell clusters) are striated, fusiform,
with well-marked elongated nuclei, plexiform in arrangement,
and embedded in densely packed connective tissue” (Keith and
Flack, 1907). Since then, extensive investigations of the human
SAN structure by many others (Lev, 1954; Hudson, 1960;
James, 1961; Truex et al., 1967; Demoulin and Kulbertus, 1978;
Matsuyama et al., 2004) have confirmed the extensive fibrotic
pattern within the node. Fibrosis provides an encompassing,
honeycomb-like, structural support composed of a network of
collagen sheaths of endomysium (Sanchez-Quintana et al., 2002)
(Figure 1B). These data show that interstitial fibrosis within
the normal SAN builds scaffolding to “house” the sophisticated
SAN myocytes and may be necessary to maximize electrical
insulation and safe propagation in the SAN complex (Davies
and Pomerance, 1972; Fedorov et al., 2010b, 2012) (Figure 1B).
Furthermore, the human SAN is electrically insulated from the
surrounding atria by fibrosis and fatty tissue (Lev, 1954; Sanchez-
Quintana et al., 2005; Monfredi et al., 2010; Fedorov et al., 2010b)
except for distinct SACPs, which electrically connect the SAN to
FIGURE 1 | (A) Left: Drawing of the posterior human atrial anatomy from
(Keith and Flack, 1907), with SAN outlined in red. Right: Histological cross
section of the SAN (red outline) connected to the atria by a SACP (yellow
outline). The SAN is seen to be isolated from the atria by sup-epicardial fat
and connective tissue. Modified from Fedorov et al. (2010b, 2012) with
permission. (B) 1—Scanning electron micrograph of the SAN and nodal
artery (NA) of a cross section through the CT after digestion of the nodal
cells. The collagenous sheaths of endomysial fibrosis formed a complex
network in the gaps between the nodal cells, whereas occasional
perimysial septums were seen between them. 2—Scanning electron
micrograph of non-macerated SAN cells (N), which are encased in dense
and coarse endomysial sheaths (yellow arrows) in a specimen from a 75
year old. 3—Scanning electron micrograph of a cross section through the
CT, after digestion, from a specimen of 70 years shows a diffuse notable
excess of endomysial sheaths (yellow arrows) indicating focal interstitial
reactive fibrosis. Vascular space (V) corresponds to a coronary vein.
4—Scanning electron micrograph of non-macerated cross section through
the body of the CT shows mainly longitudinal fibers (H) with intermingling
oblique (O) or lateral (L) fibers. From Sanchez-Quintana et al. (2002) with
permission. (C) Graph showing percentage of fibrous connective tissue
volume to the total SAN volume, mean value, and standard deviation. From
Shiraishi et al. (1992); used with permission. (D) Fibrosis in the SAN is
increased in HF vs. control dog. Left: A structural model of the control
canine SAN complex and SACPs. Middle: histological sections showing
upregulated fibrotic and fatty content in SAN complex (black outline) and
SACP in HF (bottom, blue box) compared to control (top, green box). Right:
A structural model of the heart failure SAN complex and SACPs,
(Continued)
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FIGURE 1 | Continued
showing upregulated intranodal fibrosis (blue fibrotic strands). Modified
from Lou et al. (2014) with permission. Abbreviations: CT, crista terminalis;
Endo, endocardium; Epi, epicardium; HF, heart failure; IAS, interatrial
septum; PV, pulmonary veins; RAA, right atrial appendage; RV, right
ventricle; SACP, sinoatrial conduction pathway; SAN, sinoatrial node; SVC
and IVC, superior and inferior vena cava.
the right atrium (Fedorov et al., 2012). Integral to SAN function,
fibrotic and fatty insulation of the SAN prevents the depression of
pacemaker automaticity from the hyperpolarizing electrical load
of the atrial myocardium (Joyner and van Capelle, 1986).
SAN FIBROSIS INCREASES WITH HEART SIZE AND AGE
Considerable physiological and structural evidence support the
generalization that large mammals (including human, dog, pig,
yak, horse, etc.) have a more compact and distinct SAN struc-
ture than smaller mammals (Keith and Flack, 1907; James, 1961;
Opthof et al., 1987; Fedorov et al., 2009, 2012; Duan et al., 2012;
Lou et al., 2013, 2014; Glukhov et al., 2015). Histological studies
clearly demonstrated that interstitial fibrosis is an inherent com-
ponent of normal SAN structure and can be traced from newborn
hearts (Lev, 1954; Shiraishi et al., 1992; Alings et al., 1995). The
size of the heart, as well as its mechanical demands, increases dra-
matically throughout life and may have a major effect on SAN
structure and function. In 1954, Lev published the first detailed
study of structural changes of the SANwith age in 54 human SAN
samples ranging from 4 months gestation to 90 years of age; this
exhaustive investigation revealed that the SAN tissue was already
clearly discernable from the atrial tissue at 5 months gestation,
particularly due to the greater abundance of fibroblasts and dis-
tinctly higher number of collagen fibers (Lev, 1954). Collagen
content in the human infant SAN is about 24% and this number
climbs to about 70% fibrosis in the adult heart (Shiraishi et al.,
1992; Alings et al., 1995) (Figure 1C). This natural correlation
between aging and increased fibrotic content in the SAN has also
been documented in animal models, for example SAN fibrosis in
mouse rises from 12–17% at 3 months to 23–25% at 12 months
(Hao et al., 2011; Glukhov et al., 2015). The age-induced increase
of SAN fibrosis is strongly correlated with slowed intrinsic heart
rate as well as slowed SAN conduction in human and mammalian
hearts (Kuga et al., 1993; Sanders et al., 1994; Noujaim et al.,
2004; Hao et al., 2011; Akoum et al., 2012). The SAN modeling
study by Oren and Clancy (2010) is in agreement with a study by
Fahrenbach et al. (2007): fibrosis correlates with slowed intrinsic
conduction through twomechanisms: (1) heterocellular coupling
enables the fibroblast to depolarize the cardiomyocytes (or act
as a current sink), (2) fibroblasts physically separate the pace-
maker cardiomyocytes, slowing SAN rhythm through a reduction
in mutual entrainment (Jalife, 1984).
Apart from aging, a natural size-to-fibrotic content relation-
ship is evidenced in the gradual increase in SAN percent fibrosis
as the size of the species increases. The adult mouse SAN is com-
posed of less fibrosis (Hao et al., 2011; Glukhov et al., 2015) than
the adult cat SAN, which consists of 27% fibrosis (Alings et al.,
1995). The healthy adult canine SAN has a range of 22–30% fibro-
sis (Glukhov et al., 2013; Lou et al., 2014), while the normal adult
human SAN shows roughly 45% fibrosis (Alings et al., 1995). The
contribution of increased intranodal fibrosis in large mammals
to their functional demands is not completely clear, but as the
atrial tissue increases in large vs. small hearts, more insulation
around the SAN may be necessary to protect it from the electrical
and mechanical load of the atria (Joyner and van Capelle, 1986).
Universally, large mammals have slower heart rates vs. smaller
animals as established by Noujaim et al.’s multi-species study
(Noujaim et al., 2004). Based on the studies discussed above, we
suggest that intranodal fibrosis is inversely correlated with intrin-
sic SAN rhythm and conduction, and directly correlated with age
and heart size.
FIBROSIS PROVIDES MECHANICAL PROTECTION FOR THE SAN AND
PREVENTS PATHOPHYSIOLOGICAL HEART RATE RESPONSES TO
ATRIAL STRETCH AND PRESSURE
In addition to structural scaffolding and electrical insulation from
the atria, interstitial fibrosis within the SAN can prevent it from
increased interstitial volume changes due to stretch or compres-
sion. As the natural growth during the life span or size of the
animal increases, the size and thickness of the atria also increases
to meet contractile demands (Sanchez-Quintana et al., 2002).
Mechanical stretch is a powerful myogenic modulator of SAN
function (Brooks and Lange, 1977); in fact, possibly as a local reg-
ulator of heart rate, stretch and/or increased intra-atrial pressure
can increase SAN rhythm, whereas compression and/or increased
arterial pressure in the SAN artery may lead to slowing of SAN
rhythm (James and Nadeau, 1962; Lange et al., 1966; Hashimoto
et al., 1967). These local responses to stretch and pressure may be
carried out through stretch-activated channels in pacemaker cells
and SAN fibroblasts, which have been shown to electrically cou-
ple with SANmyocytes in some studies (Kohl et al., 1994; Kamkin
et al., 2003; Cooper and Kohl, 2005; Fahrenbach et al., 2007; Oren
and Clancy, 2010). By providing a relatively tough casing for the
compact SAN, fibrosis could prevent the node from overstretch-
ing due to the mechanical pressures of the atrial myocardium
(Alings et al., 1995).
FIBROSIS IN SAN DYSFUNCTION
INCREASING FIBROSIS WITHIN THE SAN PACEMAKER COMPLEX IS
ASSOCIATED WITH SND AND ARRHYTHMIAS
SND is conceptualized as a spectrum of heart rhythm distur-
bances including bradycardia, sinus pauses/arrest, exit block,
“inappropriate” sinus tachycardia and re-entrant arrhythmias,
(Alonso et al., 2014; Jensen et al., 2014). It is largely a dis-
ease of the elderly and its incidence increases in an exponential
manner with age (Mandel et al., 1999; Adan and Crown, 2003;
Dobrzynski et al., 2007). Although human SND can be induced
by a number of different pathophysiological mechanisms such as
drug effects, autonomic imbalances, cardiomyopathy and electro-
physiological alterations, SAN structural abnormalities have been
commonly observed in these dysfunctions and are significantly
associated with HF, SAN ischemia, and inflammatory conditions
(Jordan et al., 1978; Adan and Crown, 2003; Sanders et al., 2004;
Kottkamp, 2012). In 1907, Keith and Flack saw a “definite increase
in the amount of fibrous tissue” present in the SAN from patho-
logical hearts (Keith and Flack, 1907). Later, Hudson emphasized
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the association of extensive fibrotic lesions in the human SAN
with established arrhythmia, especially AF, and suggested that
temporary arrhythmias may be associated with minor fibrotic
lesions in the SAN (Hudson, 1960). Thery et al. demonstrated
a direct correlation between SAN fibrosis and the occurrence
of tachy-brady syndrome (Thery et al., 1977). Tachy-brady syn-
drome, or tachy-brady arrhythmias, have been explained as “the
heart rate alternating between too fast and too slow,” where ter-
mination of paroxysmal tachycardia “may be followed by long
atrial pauses lasting several seconds, which can provoke another
tachyarrhythmia paroxysm” (Figure 2A) (Moss and Davis, 1974;
Lou et al., 2013, 2014). While the natural increase in SAN fibrosis
observed with aging and heart size is not directly associated with
SND, degenerative loss of SAN pacemaker cells and their replace-
ment with fibrosis tissue is frequently evident upon pathologic
examination of specimens from patients with SND (Birchfield
et al., 1957; Davies and Pomerance, 1972; Thery et al., 1977; Hurle
et al., 2006; Yeh et al., 2009).
EXCESSIVE FIBROSIS LEADS TO CONDUCTION BLOCKS AND REENTRY
IN THE SAN PACEMAKER COMPLEX
Upregulated interstitial fibrosis may lead to disruption of the
continuity of electrically coupled myocytes (Nguyen et al.,
2014), which alters the delicate balance between depolarized cells
(source) and the resting tissue ahead (sink), thereby disrupting
SAN pacemakers’ mutual entrainment (Jalife, 1984; Delmar et al.,
1986; Michaels et al., 1987). As such, too much fibrosis slows
activity of primary pacemaker clusters, as well as enhances beat-
to-beat variability and atrial arrhythmias due to competition
between multiple primary and subsidiary/latent pacemaker clus-
ters within and outside the SAN pacemaker complex (Glukhov
et al., 2013). Increased nodal fibrosis can cause slowed and decre-
mental conduction within the SAN complex, especially in the
SACPs (Figure 1D), leading to SAN exit block and long pauses,
especially after tachycardia termination. Specifically, the atrial
tachyarrhythmia or fast pacing depresses conduction/excitability
in the structurally remodeled poorly coupled SACP (Figure 1D)
which enhances source-sink mismatch and leads to exit block
from the SAN after tachyarrhythmia termination, which can give
rise to tachy-brady syndrome and cardiac arrest (Fedorov et al.,
2010a; Glukhov et al., 2010, 2013; Hao et al., 2011; Swaminathan
et al., 2011; Froese et al., 2012; Lou et al., 2014). Intramural
optical mapping studies integrated with micro-structural anal-
ysis directly revealed that fibrosis could also lead to intranodal
longitudinal and transverse conduction blocks and cause SAN
micro- and macro-reentry (Glukhov et al., 2013; Lou et al., 2014)
(Figures 2B–D). Interestingly, SAN macro-reentry (where sig-
nal travels from the one SACP to the atria and then back to
the SAN through another SACP) will lead to tachycardia, but
micro-reentry inside the SAN may lead to exit block in the
FIGURE 2 | (A) Example of Tachy-Brady arrhythmia often observed in
structurally remodeled hearts with upregulated intranodal fibrosis. Atrial
Fibrillation or Tachycardia leads to Bradycardia (long pauses) due to SAN
exit block, followed by recovery of sinus rhythm or new Tachycardia
event. ECG (black) and Optical Action Potentials (green and blue).
Modified from Lou et al. (2013) with permission. (B) Enlarged epicardial
view of 3D canine SAN model based on structural and functional data
from optical mapping experiments. The SAN is demarcated from the
atrium (green) by 3 bifurcating coronary arteries (light blue) and
connective tissue (light purple). The yellow bundles show SACPs that
electrically connect the SAN to the atrium. (C) Macro-reentry between
the SAN and atria that occurred in the structurally remodeled canine
heart after cessation of atrial tachypacing. Path of macro-reentry
correlated with fibrotic strands within SAN. (D) SAN micro-reentry
transformed from the previous macro-reentry is shown. Fibrosis strands
were the structural substrates anchoring micro-reentry to this area. (B–D)
modified from Glukhov et al. (2013) with permission. Abbreviations as
seen in Figure 1.
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SACP and severe bradycardia (Glukhov et al., 2013) (Figure 2).
Histological analysis revealed that these arrhythmias required
intranodal fibrotic strands not present in healthy hearts, indicat-
ing a critical role of intranodal fibrosis in creating structural sub-
strates for SAN macro- and micro-reentry and atrial arrhythmias
(Glukhov et al., 2013; Lou et al., 2014).
Importantly, disease-induced increases in interstitial fibrosis
can abnormally insulate latent atrial pacemaker clusters thereby
increasing their pacemaking properties (Boineau et al., 1988;
Anderson et al., 2009; Atkinson et al., 2013; Dobrzynski et al.,
2013). We recently demonstrated this novel mechanism in a
mouse model of Calsequestrin 2 knockout, wherein increased
pathological fibrosis indeed insulated latent atrial pacemaker
clusters that competed with the SAN, causing heterogeneous con-
duction within the atria and subsequently AF and ventricular
tachycardia (Glukhov et al., 2015). However, Verheule et al. found
significant depression of atrial conduction and higher inducibility
of AF in a mouse model of atria-specific TGF-β1 overexpression
but no evidence of SAN dysfunction, indicating upregulation of
atrial fibrosis alone may not be sufficient to cause SAN dysfunc-
tion (Verheule et al., 2004).
It is not always clear whether fibrosis upregulation always pre-
cedes SAN dysfunction, or if fibrosis is generated as a response
to SAN dysfunction. However, in SND animal models and recent
clinical late-gadolinium MRI studies (Akoum and Marrouche,
2014) where structural remodeling in the SAN was studied,
upregulated fibrosis in the SAN pacemaker complex was found
(Sakabe et al., 2005; Hao et al., 2011; Herrmann et al., 2011;
Swaminathan et al., 2011; Froese et al., 2012; Nakao et al., 2012;
Glukhov et al., 2013; Wolf et al., 2013; Lou et al., 2014).
DISEASE-INDUCED FIBROBLAST-MYOCYTE COUPLING
Additionally, some studies have suggested that fibroblast-myocyte
coupling (Kohl et al., 1994; Camelliti et al., 2004) can increase
during pathological structural remodeling (e.g., MI and HF)
(Kamkin et al., 2001, 2002; Vasquez et al., 2010); however, the
existence of these electrical connections is still up for debate (Kohl
and Gourdie, 2014). Depending on membrane potential, cou-
pling and distribution, the fibroblast-pacemaker cell connections
can increase or decrease the source-sinkmismatch, thus accelerat-
ing or decelerating the pacemaking of the SAN (Fahrenbach et al.,
2007). Increased coupling with interspersed fibroblasts may cre-
ate abnormal cell-to-cell interactions as well as interrupt electrical
coupling between SANmyocytes (decreasedmutual entrainment)
within the SAN complex, which has been shown in modeling
(Oren and Clancy, 2010) and cell culture (Fahrenbach et al.,
2007) studies. Furthermore, excessive extracellular matrix protein
deposition by fibroblasts within the node can increase stiffness,
which could impede the normal myogenic response of the SAN to
changes in either stretch or arterial pressure, as mentioned above.
MULTIPLE MECHANISMS UPREGULATE FIBROSIS IN THE SAN
Abnormal proliferation of fibroblasts and excessive secretion of
ECM proteins have been shown to underlie cardiac fibrosis (Fan
et al., 2012). The development of SAN arrhythmias have also been
shown to occur in parallel with the loss of pacemaker cells (Hurle
et al., 2006; Herrmann et al., 2011; Swaminathan et al., 2011; Wu
and Anderson, 2014), leading to activated and reparative fibrob-
lasts that replace dead cardiomyocytes and additional collagen
deposition (Davies and Pomerance, 1972; Burstein and Nattel,
2008; Akoum et al., 2012). These deposits may form large, non-
compliant areas of collagenous fibrosis devoid of cardiomyocytes,
as in myocardial infarction(de Jong et al., 2011), or it may lead to
increased intranodal fibrosis, as seen in HF (Figure 1D).
From the limited mechanistic studies on fibrosis within the
SAN, there are multiple mechanisms believed to upregulate
intranodal fibrosis. Myofibroblasts, the activated phenotype of
fibroblasts, are known to underlie the excessive deposition of
ECM proteins and are more mobile and contractile than fibrob-
lasts (Davis and Molkentin, 2014). Overexpression of myocardial
transforming growth factor β1 (TGF-β1) in mice has been shown
to selectively increase fibrosis in the atria by causing a cellular
transition from fibroblast to the activated myofibroblast pheno-
type (Nakajima et al., 2000; Vasquez et al., 2011). However, the
presence of activated myofibroblasts is yet to be demonstrated in
the SAN.
Another mechanism believed to be associated with increased
fibrosis is the upregulation of Angiotensin II (Ang II). Circulating
Ang II activates NADPH oxidase and increases oxidized calmod-
ulin kinase II, leading to SAN cell apoptosis and fibrosis
(Swaminathan et al., 2011). Ox-CaMKII-mediated loss of func-
tional SAN cells contributes to SAN dysfunction and sudden car-
diac death (Wu and Anderson, 2014). Recently, we demonstrated
that fibrosis is increased within the SAN and could contribute
to the slowed heart rate in a mouse model of catecholaminergic
polymorphic ventricular tachycardia, a human arrhythmic dis-
ease (Glukhov et al., 2015). In this model of abnormal calcium
(Ca2+) leak via the ryanodine receptors from the sarcoplasmic
reticulum, increased fibrosis could either be due to upregulation
of CaMKII secondary to altered Ca2+ signaling and/or SAN cell
death leading to replacement with connective tissue.
Given the significant role that fibrotic remodeling plays in
SND, anti-fibrotic approaches may present therapeutic options
for this disease. For example, the ACE inhibitor Enalapril has been
shown to reduce SAN fibrosis and SND in a four-week canine
model of atrial tachycardia (Sakabe et al., 2005). Corticosteroids
have also been shown to reduce TGF-β1 and fibrosis in mouse
lungs (Miller et al., 2006), and promising results in patients with
complete AV block due to cardiac sarcoidosis have been observed
(Selan et al., 2014). These results suggest that corticosteroids may
prevent and/or restore fibrosis-induced SAN conduction impair-
ment, but no study has specifically investigated if this approach is
feasible.
FUTURE DIRECTIONS AND CONCLUSION
Even after one century of extensive research on the SAN, the lack
of understanding of the human SAN complexity remains a crit-
ical barrier to the optimal treatment of heart rhythm disorders.
Studies on explanted human SAN are necessary to determine
its microstructure as well as structural and mechanistic role
of fibrosis in normal as well as diseased hearts. Novel imag-
ing techniques such as MRI or microCT (Akoum et al., 2012;
Stephenson et al., 2012; Disertori et al., 2014) should be employed
in addition to histological analyses to identify the intact structure
www.frontiersin.org February 2015 | Volume 6 | Article 37 | 5
Csepe et al. Fibrosis in the sinoatrial node
as well as the contribution of fibrosis to SAN function and
dysfunction.
Heterogeneous distribution of fibrosis within and around the
SAN pacemaker complex plays a crucial role in proper SAN func-
tion by providing (1) structural and functional integrity/stability
of the SAN (2) electrical insulation of SAN myocyte clusters and
the entire SAN complex, apart from SACPs, preventing depres-
sion of pacemaker automaticity from the hyperpolarizing effect
of the surrounding atria (3) mechanical protection from patho-
physiological heart rate changes due to stretch and pressure from
the contractile force of the atria.
The protective role that fibrosis plays in healthy hearts is
necessary for proper SAN function, but this role becomes patho-
physiological when fibrosis is upregulated in cardiac diseases,
leading to (1) slowed SAN rhythm due to fibrosis replacement
of pacemaker cells (2) beat-to-beat variability and slowed intra-
nodal conduction due to decreased electrical coupling between
SAN myocytes and pacemaker cell clusters (3) long pauses due
to source–sink mismatch causing exit block in the SACPs (4)
SAN micro- and macro-reentry due to fibrosis-induced conduc-
tion dissociation in the SAN. All of these pathological conditions
can lead to arrhythmias such as tachy-brady syndrome and AF.
By continuing to expand our knowledge of the complex structure
that makes up the SAN and exploring the multiple mechanisms
involved in fibrosis upregulation, we will come closer to providing
new and less invasive treatment options for a growing population
of aging patients suffering from SND.
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